Insulin secretagogue

0 marketed 1 in Phase 3 1 in Phase 2

This page covers all Insulin secretagogue drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting ATP-sensitive potassium channels.

Targets

ATP-sensitive potassium channels

Phase 3 pipeline (1)

Phase 2 pipeline (1)